Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hercules Technology Growth Capital, Inc.
Hercules Technology Expects Realized Gain from the Announced Acquisition of Sirtris Pharmaceuticals, Inc. by GlaxoSmithKline
May 10th, 2008
Hercules Technology Growth Capital, Inc. (NASDAQ:HTGC), the premier specialty finance company providing venture debt and equity to venture capital and private equity backed technology and life science companies at all stages of development, announced that it expects to realize a potential gain as a result of the announced acquisition of Sirtris Pharmaceuticals for $720 million by GlaxoSmithKline. Hercules expects to provide details at its earnings call on May 8, 2008. GlaxoSmithKline announced on April 22, 2008 that the company has entered into a definitive agreement with Sirtris Pharmaceuticals to acquire the company for approximately $720 million through a cash tender...
Source: Law & Health Weekly (2008-05-10)
|
